作者
Saeed Kachalaki, Mina Ebrahimi, Leila Mohamed Khosroshahi, Sina Mohammadinejad, Behzad Baradaran
发表日期
2016/6/30
来源
European journal of pharmaceutical sciences
卷号
89
页码范围
20-30
出版商
Elsevier
简介
The effectiveness of chemotherapy is one of the main challenges in cancer treatment and resistance to classic drugs and traditional treatment processes is an obstacle to this goal. Drug resistance that may be inherent or adventitious can cause poor treatment outcome and tumor relapse. In most cases, resistance to a drug can lead to resistance to many other drugs structure and function of which is not necessarily similar to the first drug. This phenomenon is the main mechanism behind failure of many of metastatic cancers. There are various molecular mechanisms involved in multidrug resistance, including change in the activity of membrane transporters (such as ABC transporters), increase of drug metabolism, change of the target enzyme (such as mutations that change thymidylate synthase and topoisomerases), promotion of DNA damage repair, and escape from drug induced apoptosis. Clinical and laboratory …
引用总数
2016201720182019202020212022202320249232823191813117
学术搜索中的文章
S Kachalaki, M Ebrahimi, LM Khosroshahi… - European journal of pharmaceutical sciences, 2016